CollPlant Biotechnologies (CLGN) Liabilities and Shareholders Equity (2017 - 2025)
Historic Liabilities and Shareholders Equity for CollPlant Biotechnologies (CLGN) over the last 9 years, with Q3 2025 value amounting to $14.1 million.
- CollPlant Biotechnologies' Liabilities and Shareholders Equity rose 6267960.97% to $14.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.3 million, marking a year-over-year decrease of 1727.15%. This contributed to the annual value of $18.7 million for FY2024, which is 4517.38% down from last year.
- Per CollPlant Biotechnologies' latest filing, its Liabilities and Shareholders Equity stood at $14.1 million for Q3 2025, which was up 6267960.97% from $17.4 million recorded in Q2 2025.
- In the past 5 years, CollPlant Biotechnologies' Liabilities and Shareholders Equity ranged from a high of $55.0 million in Q2 2021 and a low of $17208.0 during Q1 2025
- In the last 5 years, CollPlant Biotechnologies' Liabilities and Shareholders Equity had a median value of $34.1 million in 2023 and averaged $27.4 million.
- Per our database at Business Quant, CollPlant Biotechnologies' Liabilities and Shareholders Equity soared by 8593135.93% in 2022 and then crashed by 9991.53% in 2024.
- Quarter analysis of 5 years shows CollPlant Biotechnologies' Liabilities and Shareholders Equity stood at $51.2 million in 2021, then fell by 26.27% to $37.8 million in 2022, then dropped by 9.64% to $34.1 million in 2023, then plummeted by 45.17% to $18.7 million in 2024, then dropped by 24.7% to $14.1 million in 2025.
- Its Liabilities and Shareholders Equity was $14.1 million in Q3 2025, compared to $17.4 million in Q2 2025 and $17208.0 in Q1 2025.